A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Ark Investment Management LLC holds 146,329 shares of URGN stock, worth $1.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
146,329
Previous 161,525 9.41%
Holding current value
$1.95 Million
Previous $2.42 Million 9.41%
% of portfolio
0.02%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$13.81 - $19.33 $209,856 - $293,738
-15,196 Reduced 9.41%
146,329 $2.19 Million
Q4 2023

Jan 17, 2024

SELL
$10.87 - $15.93 $584,229 - $856,189
-53,747 Reduced 24.97%
161,525 $2.42 Million
Q3 2023

Oct 18, 2023

BUY
$8.84 - $22.64 $118,049 - $302,334
13,354 Added 6.61%
215,272 $3.02 Million
Q2 2023

Jul 10, 2023

SELL
$8.75 - $14.29 $602,245 - $983,552
-68,828 Reduced 25.42%
201,918 $2.09 Million
Q1 2023

Apr 17, 2023

BUY
$7.99 - $11.02 $589,725 - $813,364
73,808 Added 37.48%
270,746 $2.5 Million
Q4 2022

Jan 24, 2023

SELL
$7.55 - $11.9 $639,960 - $1.01 Million
-84,763 Reduced 30.09%
196,938 $0
Q3 2022

Oct 17, 2022

SELL
$7.21 - $9.41 $147,249 - $192,180
-20,423 Reduced 6.76%
281,701 $2.34 Million
Q2 2022

Jul 11, 2022

SELL
$5.12 - $8.74 $160,501 - $273,981
-31,348 Reduced 9.4%
302,124 $1.61 Million
Q1 2022

Apr 19, 2022

BUY
$5.92 - $9.73 $870,115 - $1.43 Million
146,979 Added 78.81%
333,472 $2.91 Million
Q4 2021

Jan 28, 2022

SELL
$9.03 - $19.13 $520,778 - $1.1 Million
-57,672 Reduced 23.62%
186,493 $1.77 Million
Q3 2021

Nov 12, 2021

SELL
$14.31 - $18.39 $1.03 Million - $1.33 Million
-72,083 Reduced 22.79%
244,165 $4.11 Million
Q2 2021

Aug 05, 2021

BUY
$15.2 - $20.94 $370,545 - $510,475
24,378 Added 8.35%
316,248 $4.83 Million
Q1 2021

May 13, 2021

BUY
$17.99 - $26.96 $3.92 Million - $5.88 Million
218,101 Added 295.65%
291,870 $5.69 Million
Q4 2020

Feb 12, 2021

BUY
$17.54 - $25.43 $693,829 - $1.01 Million
39,557 Added 115.62%
73,769 $1.33 Million
Q3 2020

Oct 30, 2020

SELL
$18.81 - $26.42 $244,454 - $343,354
-12,996 Reduced 27.53%
34,212 $660,000
Q2 2020

Aug 11, 2020

BUY
$16.5 - $29.7 $501,385 - $902,493
30,387 Added 180.65%
47,208 $1.23 Million
Q1 2020

May 14, 2020

BUY
$13.68 - $34.6 $10,889 - $27,541
796 Added 4.97%
16,821 $300,000
Q4 2019

Jan 31, 2020

BUY
$21.11 - $34.86 $37,786 - $62,399
1,790 Added 12.57%
16,025 $535,000
Q3 2019

Nov 12, 2019

BUY
$23.83 - $36.44 $16,823 - $25,726
706 Added 5.22%
14,235 $339,000
Q2 2019

Jul 30, 2019

BUY
$32.75 - $40.35 $148,095 - $182,462
4,522 Added 50.21%
13,529 $486,000
Q1 2019

May 13, 2019

SELL
$35.47 - $54.55 $81,261 - $124,974
-2,291 Reduced 20.28%
9,007 $333,000
Q4 2018

Feb 01, 2019

BUY
$38.35 - $50.39 $1,534 - $2,015
40 Added 0.36%
11,298 $486,000
Q3 2018

Nov 07, 2018

BUY
$41.65 - $51.7 $75,803 - $94,094
1,820 Added 19.28%
11,258 $532,000
Q2 2018

Aug 07, 2018

SELL
$48.35 - $65.33 $196,494 - $265,501
-4,064 Reduced 30.1%
9,438 $470,000
Q1 2018

May 14, 2018

BUY
$38.64 - $57.54 $162,983 - $242,703
4,218 Added 45.43%
13,502 $671,000
Q4 2017

Feb 12, 2018

BUY
$27.28 - $43.26 $253,267 - $401,625
9,284
9,284 $345,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $302M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.